Bronchiolitis obliterans. Medical search

Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.

An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a "pneumonia-like" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.

Inflammation of the BRONCHIOLES.

The transference of either one or both of the lungs from one human or animal to another.

Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.

An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.

A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking.

A fibrillar collagen found widely distributed as a minor component in tissues that contain COLLAGEN TYPE I and COLLAGEN TYPE III. It is a heterotrimeric molecule composed of alpha1(V), alpha2(V) and alpha3(V) subunits. Several forms of collagen type V exist depending upon the composition of the subunits that form the trimer.

Substances added to foods and medicine to improve the quality of taste.

An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.

Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.

Presence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma.

The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another.

Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.

Inhaling liquid or solids, such as stomach contents, into the RESPIRATORY TRACT. When this causes severe lung damage, it is called ASPIRATION PNEUMONIA.

Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.

A characteristic symptom complex.

A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.

An atrophic and sclerotic condition of the head of the PENIS, glans penis. Sometimes it leads to stenosis and occasionally obliteration of the external meatal orifice.

Pathological processes involving any part of the LUNG.

Carrier of aroma of butter, vinegar, coffee, and other foods.

Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.

A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.

Irrigation of the nose with saline or irrigation solutions for diagnostic or therapeutic purposes. It is used to remove irritants, allergens, or microorganisms from the nose.

The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from THERAPEUTIC IRRIGATION in that the irrigate is removed within minutes, but the instillate is left in place.

Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.

X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.

Tomography using x-ray transmission and a computer algorithm to reconstruct the image.

The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.

Endoscopic examination, therapy or surgery of the bronchi.

Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.

Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.

A racemic mixture of d-epinephrine and l-epinephrine.

Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.

Washing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. It is very useful in the diagnosis of diffuse pulmonary infiltrates in immunosuppressed patients.

Infection of the lung often accompanied by inflammation.

The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.

A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.

Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP-85-002, 1985) (Merck, 11th ed).

Virus diseases caused by the ADENOVIRIDAE.

A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.

A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.

A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.

A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.

The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed)

A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.

Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.

The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.

Substances that reduce or suppress INFLAMMATION.

An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.

Disease having a short and relatively severe course.

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.

The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.

Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. (1/382)

Leukemic patients receiving marrow from HLA-identical sibling donors were randomized to treatment with either busulfan 16 mg/kg (n = 88) or total body irradiation ([TBI] n = 79) in addition to cyclophosphamide 120 mg/kg. The patients were observed for a period of 5 to 9 years. Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =.01) and hemorrhagic cystitis (32% v 10%, P =.003). Acute graft-versus-host disease (GVHD) was similar in the two groups, but the 7-year cumulative incidence of chronic GVHD was 59% in the busulfan-treated group versus 47% in the TBI group (P =.05). Death from GVHD was more common in the busulfan group (22% v 3%, P <.001). Obstructive bronchiolitis occurred in 26% of the busulfan patients but in only 5% of the TBI patients (P <.01). Complete alopecia developed in 8 busulfan patients and partial alopecia in 17, versus five with partial alopecia in the TBI group (P <.001). Cataracts occurred in 5 busulfan-treated patients and 16 TBI patients (P =.02). The incidence of relapse after 7 years was 29% in both groups. Seven-year transplant-related mortality (TRM) in patients with early disease was 21% in the busulfan group and 12% in the TBI group. In patients with more advanced disease, the corresponding figures were 64% and 22%, respectively (P =.004). Leukemia-free survival (LFS) in patients with early disease was 68% in busulfan-treated patients and 66% in TBI patients. However, 7-year LFS in patients with more advanced disease was 17% in the busulfan group versus 49% in the TBI group (P <.01). In patients with chronic myeloid leukemia (CML) in first chronic phase, 7-year LFS was 72% and 83% in the two groups, respectively. (+info)

Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. (2/382)

A 16-year-old boy developed bronchiolitis obliterans (BO) 10 years after BMT for myelodysplastic syndrome. Although the patient complained of almost no dyspnea on exertion, he had mild hypercapnea with a markedly reduced forced expiratory volume of 0.32 l. Chest X-rays showed occasional bilateral minimal pneumothoraces, which is in accordance with the existence of multiple small bullae found on the pleural surface at video-assisted thoracic surgery. Histologic examination of the biopsied lung revealed BO. This case indicates that BO in adolescence following BMT and possible chronic GVHD may be masked because of lung immaturity at BMT, and BO after BMT may be associated with multiple pleural bullae. (+info)

Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. (3/382)

Constrictive bronchiolitis obliterans is rare, and the pathogenesis of the disease often remains unknown. This study reports on the case of a 38 yr-old female with constrictive bronchiolitis obliterans and paraneoplastic pemphigus associated with malignant lymphoma. The patient developed progressive obstructive lung disease. The chest radiograph showed almost normal lungs. Paraneoplastic pemphigus is a newly described syndrome in which patients have autoantibodies binding to some epithelia, including in the respiratory tract. The disease develops in association with non-Hodgkin's lymphomas or other malignant neoplasms. The case presented here suggests that constrictive bronchiolitis obliterans associated with paraneoplastic pemphigus may be one of the facets of autoimmune responses in this context. (+info)

Peripheral blood allogeneic microchimerism in lung and cardiac allograft recipients. (4/382)

We have been investigating two parameters, donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism, to determine whether these parameters will predict a chronic rejection-free state and which recipients may be candidates for steroid withdrawal. We have identified donor antigen-specific hyporeactivity for 33% (16/48) of lung and 23% (11/47) of heart recipients. For both organ groups, the hyporeactive subgroup experienced a lower incidence of chronic rejection. The probability of donor antigen-specific hyporeactivity predicting a chronic rejection-free state is 100% for lung and 91% for heart recipients. We have identified peripheral blood allogeneic microchimerism for 77% (20/26) of lung and 36% (9/25) of heart recipients tested at 12-18 months posttransplant. Donor antigen-specific hyporeactivity correlates with a critical level of donor cells in lung recipients; the probability of high peripheral blood allogeneic microchimerism levels predicting a chronic rejection-free state in lung recipients is 100%. The results in heart recipients are not as clear with a short-, but not long-term, trend of higher chimerism levels correlating with the development of donor antigen-specific hyporeactivity. These results illustrate the usefulness of immmune parameters to predict long-term graft outcome in an organ-specific manner. (+info)

Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. (5/382)

The major cause of mortality in the long-term in lung transplant recipients is chronic rejection. This is a fibroproliferative process in the small airways leading to obliterative bronchiolitis and progressive loss of lung function, both constituting the clinical entity bronchiolitis obliterans syndrome (BOS). Granulocyte activation has been implicated as one factor behind BOS. Granulocyte markers in bronchoalveolar lavage (BAL) fluid were prospectively and longitudinally studied in order to identify possible association with BOS. BAL fluid from 266 bronchoscopy procedures performed in twelve single lung, eight bilateral lung and five heart/lung transplant recipients were analysed. The majority (19 of 25) were studied for a period of 2 yrs after surgery. Myeloperoxidase (MPO), eosinophil cationic protein (ECP) and interleukin-8 (IL-8) levels were used as indirect markers of activation and attraction of granulocytes. Five patients developed BOS. Ninety-eight episodes of acute rejection, nine of bacterial infection, 19 of cytomegalovirus pneumonitis, nine of Pneumocystis carinii infection, two of aspergillus infection and two of respiratory syncytial virus infection were diagnosed. BOS patients had significantly higher mean levels of MPO, ECP and IL-8 compared to patients without BOS, irrespective of acute rejection status. Over time, the five patients with BOS had significantly elevated BAL fluid levels of MPO and ECP as well as neutrophil percentages, and in four patients this increase preceded the clinical diagnosis of BOS by several months. Elevated bronchoalveolar lavage fluid neutrophil percentage as well as levels of the granulocyte activation markers myeloperoxidase and eosinophil cationic protein appear to be early signs of development of BOS in lung transplant recipients. (+info)

Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. (6/382)

BACKGROUND: The bronchiolitis obliterans syndrome (BOS) remains the major constraint on the long term success of lung transplantation. Neutrophils have been associated with fibrosing lung conditions and have been noted to be increased in the bronchoalveolar lavage (BAL) fluid of patients with BOS. METHODS: This study was undertaken to examine neutrophil accumulation in the BAL fluid, airway wall and lung parenchyma, as well as levels of interleukin (IL)-8 in the BAL fluid, in normal controls and lung transplant recipients with and without BOS. Bronchoscopic examination included endobronchial biopsy (EBB), BAL fluid, and transbronchial biopsy (TBB) sampling. Tissue neutrophils were identified by neutrophil elastase staining on 3 microm paraffin biopsy sections and quantified by computerised image analyser. IL-8 levels were measured in unconcentrated BAL fluid by ELISA. RESULTS: Compared with controls, airway wall neutrophilia was increased in both stable lung transplant recipients and those with BOS (p<0.05). BAL neutrophils and IL-8 levels were also increased in both groups of transplant recipients compared with controls (p<0.01), the levels being significantly higher in the BOS group (p<0.01). Neutrophil numbers in the lung parenchyma were not significantly different between the two groups of lung transplant recipients. CONCLUSION: Increased levels of neutrophils are present in the airway wall and BAL fluid of lung transplant recipients with and without BOS. BAL fluid levels of IL-8 are also increased, raising the possibility that neutrophils and/or IL-8 may play a part in the pathogenesis of BOS following lung transplantation. (+info)

Clinical and radiological characteristics of lung disease in inflammatory bowel disease. (7/382)

The pulmonary associations of inflammatory bowel disease (IBD) are poorly characterized. The clinical, physiological and high-resolution computed tomographic thorax characteristics of the lung disease in patients with IBD presenting with respiratory symptoms are described. Detailed clinical information was obtained and standard pulmonary physiological tests and thorax high-resolution computed tomography performed on 14 patients with ulcerative colitis (UC) and three with Crohn's disease (CD), 10 male, aged 38-83 yrs. Respiratory symptoms had been present for 2-50 yrs and extraintestinal manifestations were present in three (17.6%). Normal pulmonary physiology (six patients) was associated with the high resolution computed tomographic changes of bronchiectasis, mosaic perfusion and air trapping suggestive of obliterative bronchiolitis and a pattern of centrilobular nodules and branching linear opacities ("tree in bud" appearance) suggestive of either cellular bronchiolitis or bronchiolectasis with mucoid secretions. Bronchiectasis was found in 13 patients (11 UC, 2 CD), 11 had air trapping and five had a "tree in bud" appearance on computed tomography. One patient had a predominantly peripheral reticular pattern at the lung bases similar to that found in cryptogenic fibrosing alveolitis and one patient had a mixed reticular and ground-glass pattern in the midzones with a patchy distribution in the central and peripheral portions of the lungs with air trapping. Eleven patients (three with alveolitis) exhibited a clinical and/or physiological response to steroids. Pulmonary abnormalities in ulcerative colitis and Crohn's disease can present years after the onset of the bowel disease and can affect any part of the lungs. Early recognition is important as they can be strikingly steroid-responsive. (+info)

B7-1, B7-2 and class II MHC molecules in idiopathic pulmonary fibrosis and bronchiolitis obliterans-organizing pneumonia. (8/382)

Interstitial lung diseases are thought to be associated with the infiltration of activated T-lymphocytes. To induce an effective immune response, antigen-presenting cells have to not only present antigenic peptide with major histocompatibility complex (MHC) molecules to T-lymphocytes but also express B7 molecules. Therefore, the expression of B7-1, B7-2 and class II MHC molecules was investigated in lung tissues from patients with idiopathic pulmonary fibrosis (IPF) and bronchiolitis obliterans-organizing pneumonia (BOOP), and in normal lung parenchyma as a control, using immunohistochemical localization. B7-1 and B7-2 were aberrantly expressed in bronchiolar and alveolar epithelial cells, and class II MHC molecules were also aberrantly expressed in bronchiolar epithelial cells in IPF. B7-1 was aberrantly expressed in bronchiolar epithelial cells in BOOP. There was no significant difference in the expression of these proteins in alveolar macrophages between IPF and control subjects. However, B7-2 and class II MHC molecule expression in alveolar macrophages was decreased in BOOP compared with that in control subjects. Expression of CD28 and CTLA4, receptors for B7 molecules, was detected in infiltrating lymphocytes in lung tissues in IPF and BOOP. It was concluded that bronchiolar and alveolar epithelial cells may actively participate in the pathophysiology of idiopathic pulmonary fibrosis through the aberrant expression of B7 and class II major histocompatibility complex molecules. The dysregulation of these molecules in epithelial cells may lead to the activation of autoreactive T-lymphocytes, which might contribute to the pathogenesis of fibrosing lung diseases. (+info)

... respiratory bronchiolitis; BIP=bronchiolitis obliterans interstitial pneumonia; OP=organizing pneumonia; LIP=lymphoid ...

https://en.wikipedia.org/wiki/Idiopathic_interstitial_pneumonia

Bronchiolitis obliterans after aspiration of activated charcoal". Chest. 96 (3): 672-4. doi:10.1378/chest.96.3.672. PMID ...

https://en.wikipedia.org/wiki/Activated_charcoal_(medication)

Induced Bronchiolitis Obliterans: From Botanical Studies to Toxicology". Evid Based Complement Alternat Med. 2015: 1-7. doi: ... Papaverine in the plant Sauropus androgynus is linked to bronchiolitis obliterans. Papaverine is available as a conjugate of ...

https://en.wikipedia.org/wiki/Papaverine

Diacetyl and acetyl propionyl are associated with bronchiolitis obliterans. A 2018 PHE report stated that the e-cigarette ... A 2014 case report observed the correlation between sub-acute bronchiolitis and vaping. After quitting vaping the symptoms ...

https://en.wikipedia.org/wiki/Safety_of_electronic_cigarettes

bronchiolitis obliterans with organizing pneumonia (BOOP). *pulmonary fibrosis. *fatal asymmetric interstitial lung disease[13] ...

https://en.wikipedia.org/wiki/Erlotinib

Occasionally, desquamative interstitial pneumonia and bronchiolitis obliterans organizing pneumonia can be seen. Other symptoms ... The typical histopathology in flock worker's lung is bronchiolocentric interstitial pneumonitis and lymphocytic bronchiolitis ...

https://en.wikipedia.org/wiki/Flock_worker's_lung

... "flavorings-related bronchiolitis obliterans" or diacetyl-induced bronchiolitis obliterans. People who work with flavorings that ... In the year 2000 8 cases of bronchiolitis obliterans were detected in former employees of a microwave popcorn plant. Many of ... Diacetyl is known to cause the lung disease bronchiolitis obliterans in those individuals exposed to it in an occupational ... However, lung transplant rejection is very common and happens to be another setting in which bronchiolitis obliterans is known ...

https://en.wikipedia.org/wiki/Diacetyl

Such chronic rejection presents itself as bronchiolitis obliterans, or less frequently, atherosclerosis. These statistics are ...

https://en.wikipedia.org/wiki/Lung_transplantation

"Outbreak of Bronchiolitis obliterans Associated with Consumption of Sauropus androgynus in Japan - Alert of Food-Associated ... "Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan". The Lancet. 348 (9020): 83- ... Consumption of Sauropus androgynus has been reported as being associated with bronchiolitis obliterans. Sauropus androgynus is ...

https://en.wikipedia.org/wiki/Sauropus_androgynus

June 2007). "Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients". American Journal ... In histopathology the condition is bronchiolitis obliterans, which clinically presents as progressive airflow obstruction, ... Airflow obstruction not ascribable to other cause is labeled bronchiolitis obliterans syndrome (BOS), confirmed by a persistent ... "Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation". Pediatric ...

https://en.wikipedia.org/wiki/Transplant_rejection

Merriam-Webster Medical Dictionary > bronchiolitis obliterans Retrieved on August, 2010 Harber P, Saechao K, Boomus C (2006). " ... has been associated with bronchiolitis obliterans, a rare and life-threatening form of non-reversible obstructive lung disease ...

https://en.wikipedia.org/wiki/Artificial_butter_flavoring

Kalenian M; Zweiman B (March 1997). "Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 ...

https://en.wikipedia.org/wiki/Anti-Jo1

Diseases of the bronchioles include asthma, bronchiolitis obliterans, respiratory syncytial virus infections, and influenza. ... The medical condition of inflammation of the bronchioles is termed bronchiolitis. Cross sectional cut of primary bronchiole ...

https://en.wikipedia.org/wiki/Bronchiole

This is more common in cases of bronchiolitis obliterans, pulmonary fibrosis, or pulmonary hypertension. Most complications are ... women Rheumatoid-associated interstitial lung disease Bronchiolitis obliterans organizing pneumonia Obliterative bronchiolitis ... pleural thickening or effusion interstitial fibrosis bronchiectasis bronchiolitis obliterans large rheumatoid nodules single or ... follicular bronchiolitis small centrilobular nodules or tree-in-bud rare Caplan syndrome Echocardiogram (may show pulmonary ...

https://en.wikipedia.org/wiki/Rheumatoid_lung_disease

... "flavorings-related bronchiolitis obliterans"[14] or diacetyl-induced bronchiolitis obliterans.[15] People who work with ... However, lung transplant rejection is very common and happens to be another setting in which bronchiolitis obliterans is known ... Workers in several factories that manufacture artificial butter flavoring have been diagnosed with bronchiolitis obliterans, a ... "Obliterative Bronchiolitis in Workers in a Coffee-Processing Facility - Texas, 2008-2012". Morbidity and Mortality Weekly ...

https://en.m.wikipedia.org/wiki/Diacetyl

Diacetyl and acetyl propionyl are associated with bronchiolitis obliterans ("popcorn lung"), a serious lung disease. A 2015 ...

https://en.wikipedia.org/wiki/Flavored_tobacco

In 2008, Born was diagnosed with bronchiolitis obliterans, a rare and non-reversible lung disease . He died in Boulder, ...

https://en.wikipedia.org/wiki/George_Born

Airflow obstruction not ascribable to other cause is labeled bronchiolitis obliterans syndrome (BOS), confirmed by a persistent ... after onset of bronchiolitis obliterans syndrome in lung transplant recipients". American Journal of Respiratory and Critical ... In histopathology the condition is bronchiolitis obliterans, which clinically presents as progressive airflow obstruction, ... "Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation". Pediatric ...

https://en.wikipedia.org/wiki/Immune_rejection

... and bronchiolitis obliterans organizing pneumonia (BOOP) have also been reported. Diagnosis is generally by assessment of ...

https://en.wikipedia.org/wiki/Inflammatory_bowel_disease

Bronchiolitis obliterans organizing pneumonia (BOOP) is caused by inflammation of the small airways of the lungs. It is also ...

https://en.wikipedia.org/wiki/Classification_of_pneumonia

... causing bronchiolitis obliterans (constrictive bronchiolitis). Though much less frequent, it is still found the most in the ... cocktail of immune suppressant drugs is sometimes used in an attempt to halt the rapid progression of bronchiolitis obliterans ...

https://en.wikipedia.org/wiki/Pemphigus

The condition is aptly known as bronchiolitis obliterans and clinically is diagnosed as bronchiolitis obliterans syndrome (BOS ...

https://en.wikipedia.org/wiki/Inhaled_ciclosporin

ബ്രോങ്കിയൊളൈറ്റിസ് ഒബ്ലിറ്ററൻസ് സാന്ദ്രീകരണ ന്യുമോണിയ (Bronchiolitis obliterans organizing pneumonia; BOOP)[തിരുത്തുക]. ... Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001 Jan 22;161(2):158-64. PMID: 11176728 ... 2.3.6 ബ്രോങ്കിയൊളൈറ്റിസ് ഒബ്ലിറ്ററൻസ് സാന്ദ്രീകരണ ന്യുമോണിയ (Bronchiolitis obliterans organizing pneumonia; BOOP) ... ശ്വസനികാവീക്കമായിട്ടാണു (bronchiolitis) ബ്രോങ്കോന്യുമോണിയ ആരംഭിക്കുന്നത്. പഴുപ്പും നിസ്രാവവും (exudate) മൂലം ശ്വസനികയും അതിന്റെ ...

https://ml.wikipedia.org/wiki/Pneumonia

Bronchiolitis obliterans organizing pneumonia.Cited 1334 times according to GoogleScholar Bronchiolitis obliterans organizing ... Gary Epler did research on the Bronchiolitis Obliterans Organizing Pneumonia which is inflammatory bronchiolitis obliterans ... Post-breast cancer radiotherapy bronchiolitis obliterans organizing pneumonia. Drug-Induced Bronchiolitis Obliterans Organizing ... Diagnosis and treatment of constrictive bronchiolitis. Constrictive bronchiolitis obliterans: the fibrotic airway disorder. " ...

https://en.wikipedia.org/wiki/Gary_R._Epler

IL-13 is the dominant effector in toxin, infection, allergic, and post-transplant bronchiolitis obliterans models of fibrosis. ...

https://en.wikipedia.org/wiki/Interleukin_13

It manifests as dyspnea and progresses to bronchiolitis obliterans (non-reversible obstructive lung disease) via an unknown ...

https://en.wikipedia.org/wiki/Paraneoplastic_pemphigus

Diacetyl is known to cause the lung disease bronchiolitis obliterans in those individuals exposed to it in an occupational ...

https://en.wikipedia.org/wiki/Dicarbonyl

... and bronchiolitis obliterans. Extrapulmonary symptoms such as autoimmune responses, central nervous system complications, and ...

https://en.wikipedia.org/wiki/Mycoplasma_pneumoniae

This may include, among others: empyema, lung abscess, bronchiolitis obliterans, acute respiratory distress syndrome, sepsis, ... respiratory bronchiolitis interstitial lung disease, and usual interstitial pneumonia. Lipoid pneumonia is another rare cause ...

https://en.wikipedia.org/wiki/Pneumonia

Bronchiolitis obliterans after aspiration of activated charcoal". Chest. 96 (3): 672-4. doi:10.1378/chest.96.3.672. PMID ...

https://en.wikipedia.org/wiki/Activated_charcoal

... bronchiolitis obliterans (pagkakagasgas ng daanan ng hangin), malubhang respiratory distress syndrome (kawalan ng kakayahan ng ... respiratory bronchiolitis interstitial na sakit sa baga, at karaniwang interstitial na pulmonya.[29] ...

https://tl.wikipedia.org/wiki/Pulmonya

Bronchiolitis Bronchiolitis obliterans. Diffuse panbronchiolitis. Interstitial/. restrictive. (fibrosis). External agents/. ... and small airways disease known as obstructive bronchiolitis.[9] The relative contributions of these two factors vary between ... Less common conditions that may present similarly include bronchopulmonary dysplasia and obliterative bronchiolitis.[80] ...

https://en.wikipedia.org/wiki/COPD

... some patients develop bronchiolitis obliterans progressing to ARDS. Bronchiolitis obliterans with organized pneumonia can ensue ... and only intensely exposed victims showed signs like bronchiolitis obliterans in the distal part. Secondary effects of sulfur ... Irritant gas exposures predominantly affect the airways, causing tracheitis, bronchitis, and bronchiolitis. Other inhaled ... are more likely to cause severe bronchiolitis, and often have a lag of ≥ 12 h before symptoms of pulmonary edema develop. Acute ...

https://en.wikipedia.org/wiki/Acute_inhalation_injury

阻塞性細支氣管炎伴機化性肺炎（英语：Bronchiolitis obliterans organizing pneumonia） ... 細支氣管炎（英语：Bronchiolitis）阻塞性細支氣管炎. 瀰漫性

https://zh.wikipedia.org/wiki/肺炎支原體